Cardiovascular health for patients with psoriasis: a précis for front-line clinicians.
Psoriasis is a prevalent immune disease most notably recognized for its involvement of the skin and joints and for its impact on patient quality of life. More recently, it has been shown that not only do patients with psoriasis have a higher prevalence of cardiovascular risk factors such as hypertension, diabetes mellitus, obesity, smoking, and dyslipidemia, but they also appear to have an increased risk of myocardial infarction independent of these factors. Patients with severe forms of psoriasis also have been found to have increased mortality rates compared to those without psoriasis. The purpose of this review is to increase awareness of these associations among dermatologists and primary care providers to ensure that cardiovascular risk factors are evaluated and appropriately managed in patients with psoriasis.
Federman
Daniel G
DG
Department of Medicine, VA Connecticut Health Care, West Haven, Connecticut 06516, USA. daniel.federman@va.gov
Shelling
Michael L
ML
Prodanovich
Srdjan
S
Gunderson
Craig G
CG
Kirsner
Robert S
RS
D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D003880:Dermatology; D003920:Diabetes Mellitus / Q000453:epidemiology; D050171:Dyslipidemias / Q000453:epidemiology; D006801:Humans; D006973:Hypertension / Q000453:epidemiology; D009765:Obesity / Q000453:epidemiology; D015995:Prevalence; D011320:Primary Health Care; D011565:Psoriasis / Q000150:complications* / Q000453:epidemiology / Q000628:therapy; D018570:Risk Assessment; D012307:Risk Factors; D040242:Risk Reduction Behavior; D012907:Smoking / Q000453:epidemiology